about
Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.c-MET immunostaining in colorectal carcinoma is associated with local disease recurrenceOverexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinomaLoss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survivalp16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma.Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patientsProtective effect of carnosine against cisplatin-induced nephrotoxicity in mice.Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats.Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis.Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67Therapeutic role of telmisartan against acetaminophen hepatotoxicity in miceProtective effect of cannabidiol against cadmium hepatotoxicity in ratsProtective effect of naringenin against gentamicin-induced nephrotoxicity in ratsPrognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approachIncreased osteopontin expression in endometrial carcinoma is associated with better survival outcomeImmunoexpression of cyclin D1 in colorectal carcinomas is not correlated with survival outcomeA Rare Concomitant Oncocytic Adrenocortical Neoplasm and Hepatocellular Carcinoma over a Four-year Duration: A Case Report and Review of Literature
P50
Q35183529-424E3CC7-2D4E-40AE-A8CE-FDFDB7F10228Q35804089-FF1D0B28-8DAA-4449-B60C-2094331BB0C2Q36511751-BEF9B2DB-5B93-4A13-8210-EEEF7C2F1C1CQ37182611-790F9ECF-9BDC-4CB1-8AEB-FE6AFF759CFAQ37532243-DAB29B7E-35BC-4250-ACAA-5B194A0969B4Q37634828-8AD77EC4-E77B-4A42-B136-3C8D7A1496ABQ42729486-69A42BB4-DFBC-40C8-B8E0-44A73209F571Q46319113-3F362509-59B5-46DC-AF67-ACCA9C989DD5Q64989645-729CD354-D04C-449E-B373-3B2C6C89F9F4Q80362684-59826B9F-A319-4023-A3F8-14417013E83AQ84915483-B843C9BA-3B76-483B-9FD2-619C39F062B2Q87339349-743C3EEA-68AD-4734-BDB1-1DAC3C6B98BDQ87590941-ED245B21-8D86-402D-A2BD-AB456723D63CQ89997334-F9E8D746-2ED0-4DD8-BF6B-D74D5462ACC1Q90101498-BFC494DE-055E-4E3B-9A73-333F6E49FCD4Q90330118-560FA6E1-EF56-4090-8EB0-FA28F351F3A6Q91477609-608DF99B-7395-4C4E-9A03-DDC2E317141A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Wafaey Gomaa
@en
Wafaey Gomaa
@nl
type
label
Wafaey Gomaa
@en
Wafaey Gomaa
@nl
prefLabel
Wafaey Gomaa
@en
Wafaey Gomaa
@nl
P31
P496
0000-0002-6282-1037